Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

5-aminosalicylic acid agents for prevention of recurrent diverticulitis: a systematic review and meta-analysis.

Urushidani S, Kuriyama A, Matsumura M.

J Gastroenterol Hepatol. 2017 Jun 17. doi: 10.1111/jgh.13846. [Epub ahead of print]

PMID:
28623877
2.

Emerging treatments for ulcerative colitis: a systematic review.

Kokkinidis DG, Bosdelekidou EE, Iliopoulou SM, Tassos AG, Texakalidis PT, Economopoulos KP, Kousoulis AA.

Scand J Gastroenterol. 2017 Sep;52(9):923-931. doi: 10.1080/00365521.2017.1326163. Epub 2017 May 14.

PMID:
28503977
3.

Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.

Bonovas S, Fiorino G, Lytras T, Nikolopoulos G, Peyrin-Biroulet L, Danese S.

Aliment Pharmacol Ther. 2017 May;45(9):1179-1192. doi: 10.1111/apt.14023. Epub 2017 Mar 6. Review.

PMID:
28261835
4.

Adherence in ulcerative colitis: an overview.

Testa A, Castiglione F, Nardone OM, Colombo GL.

Patient Prefer Adherence. 2017 Feb 22;11:297-303. doi: 10.2147/PPA.S127039. eCollection 2017. Review.

5.

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.

Coward S, Kuenzig ME, Hazlewood G, Clement F, McBrien K, Holmes R, Panaccione R, Ghosh S, Seow CH, Rezaie A, Kaplan GG.

Inflamm Bowel Dis. 2017 Mar;23(3):461-472. doi: 10.1097/MIB.0000000000001023.

PMID:
28146003
6.

[Second Korean Guidelines for the Management of Crohn's Disease].

Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases.

Korean J Gastroenterol. 2017 Jan 25;69(1):29-54. doi: 10.4166/kjg.2017.69.1.29. Review. Korean.

7.

[Second Korean Guideline for the Management of Ulcerative Colitis].

Choi CH, Moon W, Kim YS, Kim ES, Lee BI, Jung Y, Yoon YS, Lee H, Park DI, Han DS; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases.

Korean J Gastroenterol. 2017 Jan 25;69(1):1-28. doi: 10.4166/kjg.2017.69.1.1. Review. Korean.

8.

5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Brown G.

Can J Hosp Pharm. 2016 Nov-Dec;69(6):466-472. Epub 2016 Dec 23. Review.

9.

Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.

Rowinski SA, Christensen E.

Dan Med J. 2016 Dec;63(12). pii: A5307. Review.

PMID:
27910801
10.

Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Manguso F, Bennato R, Lombardi G, Riccio E, Costantino G, Fries W.

PLoS One. 2016 Nov 15;11(11):e0166455. doi: 10.1371/journal.pone.0166455. eCollection 2016. Review.

11.

Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?

Subramanian S, Ekbom A, Rhodes JM.

Gut. 2017 Feb;66(2):362-381. doi: 10.1136/gutjnl-2016-312673. Epub 2016 Oct 6. Review.

PMID:
27802156
12.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Chande N, Townsend CM, Parker CE, MacDonald JK.

Cochrane Database Syst Rev. 2016 Oct 26;10:CD000545. Review.

PMID:
27783843
13.

Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.

D'Haens G.

Aliment Pharmacol Ther. 2016 Nov;44(10):1018-1029. doi: 10.1111/apt.13803. Epub 2016 Sep 21. Review.

PMID:
27650488
14.

Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Zhao X, Li N, Ren Y, Ma T, Wang C, Wang J, You S.

PLoS One. 2016 Aug 8;11(8):e0160500. doi: 10.1371/journal.pone.0160500. eCollection 2016.

15.

Aminosalicylates for induction of remission or response in Crohn's disease.

Lim WC, Wang Y, MacDonald JK, Hanauer S.

Cochrane Database Syst Rev. 2016 Jul 3;7:CD008870. doi: 10.1002/14651858.CD008870.pub2. Review.

PMID:
27372735
16.

Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.

Li W, Zhang ZM, Jiang XL.

Colorectal Dis. 2016 Jul;18(7):O214-23. doi: 10.1111/codi.13393. Review.

PMID:
27214762
17.

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

Timmer A, Patton PH, Chande N, McDonald JW, MacDonald JK.

Cochrane Database Syst Rev. 2016 May 18;(5):CD000478. doi: 10.1002/14651858.CD000478.pub4. Review.

PMID:
27192092
18.

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Wang Y, Parker CE, Feagan BG, MacDonald JK.

Cochrane Database Syst Rev. 2016 May 9;(5):CD000544. doi: 10.1002/14651858.CD000544.pub4. Review.

PMID:
27158764
19.

Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.

Khan MA, Ali B, Lee WM, Howden CW.

Am J Gastroenterol. 2016 Apr;111(4):579-81. doi: 10.1038/ajg.2016.24. No abstract available.

PMID:
27125717
20.

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Wang Y, Parker CE, Bhanji T, Feagan BG, MacDonald JK.

Cochrane Database Syst Rev. 2016 Apr 21;4:CD000543. doi: 10.1002/14651858.CD000543.pub4. Review.

Supplemental Content

Loading ...
Support Center